Selected sections of MRI of the brain. MRI showed diffuse increased signal on T2 FLAIR images involving lateral thalamic, midbrain, and cerebellar areas, with cerebral edema present.
A 66-year-old woman initially presented with stage IV large B-cell non-Hodgkin's lymphoma. Initial treatment achieved complete response after six cycles of rituximab and CHOP chemotherapy. The patient relapsed within 8 weeks and was treated, during summer 2003, with one cycle of rituximab and intermediate-dose cyclophosphamide, with concomitant localized radiation therapy to a subcutaneous forehead lesion. During early fall 2003, following collection of autologous peripheral blood hematopoietic stem cells, the patient received outpatient high-dose cytoreductive therapy with rituximab, ibritumomab tiuxetan (Zevalin), etoposide, and cyclophosphamide. At 4 days following stem cell re-infusion (day þ 4), she was hospitalized for fever and profound neutropenia. Despite broad-spectrum antimicrobial therapy, fevers as high as 401C persisted. On day þ 11, still febrile after resolution of the neutropenia, she developed confusion and tremors, progressing to dysphagia, aphasia, flaccid paralysis, and respiratory distress. Magnetic resonance imaging studies showed diffusely increased signal involving the lateral thalamus, midbrain, and cerebellum, compatible with extensive encephalitis (Figure 1 ). The cerebrospinal fluid (CSF) showed minimal elevation in protein, normal glucose, and no evidence of abnormal cells. Blood, urine, and CSF studies did not show evidence of bacterial, fungal, tuberculosis, herpes simplex virus, cytomegalovirus, or toxoplasma infection. The patient's central nervous system function continued to deteriorate and she died on day þ 17. West Nile virus (WNV) RNA was detected in premortem CSF samples by nucleic acid amplification (NAA) assays (real-time polymerase chain reaction-based investigational assay, Delaware Public Health Laboratory, DE, USA) and confirmed in tissue culture (Delaware Public Health Laboratory, DE, USA). Postmortem analysis of brain tissue by NAA assay and tissue culture confirmed the presence of WNV. Autopsy detected no evidence of lymphoma. All transfused blood products during the patient's clinical course, before and after stem cell transplantation, were negative for WNV by pretransfusion 'batch' screening. 1 NAA assay of available retained plasma from individual blood products transfused did not detect the virus. Serologic testing was subsequently performed on all donors and was negative. NAA assay found no evidence of WNV in remaining samples of the autologous stem cells collected 21 days prior to the initiation of the transplantation-conditioning program. The patient's day þ 15 serum was negative for IgM antibodies against WNV.
WNV is a flavivirus that causes a wide range of clinical illness, ranging from asymptomatic infection to meningoencephalitis. 2 Mosquitoes are the natural vector for transmission, with peak activity occurring during late summer and autumn months. Blood products from asymptomatic, viremic donors can also transmit the infection. 3 Human data suggest that viremia persists for less than 12 days in the immunocompetent host, but may last as long as 28 days in immunosuppressed individuals. 4, 5 The incubation period for development of disease is estimated at 3-14 days. 5 A longer period, as long as 21 days, has been observed in immunocompromised patients. 6, 7 Recent reports indicate the possibility of fatal central nervous system toxicity associated with WNV infection after hematopoietic stem cell transplantation, [8] [9] [10] and highlight the potential acquisition of infection through transfusion. 10 A mosquito vector most likely infected the patient reported here. We performed the patient's transplantation in the late summer/early fall, when Delaware had evidence of WNV transmission in the area where the patient resided. Furthermore, all blood donors, as well as the autologous stem cells, tested negative for WNV. Experimentally, components of humoral immunity, particularly IgM and IgG, appear to play critical roles in preventing dissemination of WNV infection to the central nervous system, while CD8 þ T-cells may have an important function in clearing infection from tissues and preventing viral persistence. 11 Immune suppression during an asymptomatic viremic period, particularly given the depletion of B-cells induced by rituximab and ibritumomab tiuxetan therapy, likely contributed to the development of catastrophic meningoencephalitis.
This case suggests that screening both recipient and donor for asymptomatic viremia may be reasonable before stem cell transplantation, especially during times of high mosquito activity in geographic areas affected by WNV. 
